CDER Biomarker Qualification Program

Biomarker Qualification Program

SPOTLIGHT Events & Announcements

Web content is updated for consistency with 21st Century Cures Act!

Get Started with your submission:

Resources for Biomarker Requestors


The mission of the CDER Biomarker Qualification Program (BQP) is to work with external stakeholders to develop biomarkers as drug development tools. Qualified biomarkers have the potential to advance public health by encouraging efficiencies and innovation in drug development. 

About FDA’s Biomarker Qualification Program



  • Support outreach to stakeholders for the identification and development of new biomarkers
  • Provide a framework for the review of biomarkers for use in regulatory decision-making
  • Qualify biomarkers for specific contexts of use that address specified drug development needs

Additional Information

Contact us at: CDER-BiomarkerQualificationProgram@fda.hhs.gov


Page Last Updated: 04/02/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English